Products & Pipeline

EpiCept is focused on developing novel therapies in the areas of pain and cancer.

In the area of pain, the Company is advancing prescription pain products that use a topical delivery approach, as opposed to systemic or injectable modes, for both acute and chronic pain.

In the area of cancer, the Company has two product candidates in clinical development for the treatment of solid tumors.

EpiCept invites you to learn more about these product candidates and their potential benefits to patients.